Case Study: a leading diagnostics company accelerates biomarker discovery with Elucidata's Polly

leading diagnostics company accelerates biomarker discovery 2x with Elucidata

A leading diagnostics company sought to accelerate its clinical and biomarker research but faced significant challenges. They needed to harmonize over 175 million EHR, imaging, and molecular assay records from multiple sources spanning more than a decade. To overcome this, they partnered with Elucidata and implemented its Polly platform.

Elucidata's Polly provided a holistic, AI-ready view of the patient information, successfully unifying the massive multi-modal datasets. The implementation resulted in 4x lower costs for data product generation and accelerated AI model development by 2x. Polly achieved 99.99% data accuracy and saved over 1,500 hours of manual effort, enabling the diagnostics company to achieve faster clinical research and biomarker discovery.